F06.7
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Control group: - Vision and hearing: unimpaired or sufficiently corrected (glasses, hearing aid, etc.) - Sufficient knowledge of German - Sufficient language skills (documented in the Aphasie-Check-Liste short version) - Disease status: no known neurological diseases - Cognitive status: no known impairments - Consent: consented and signed Clinical patients: - Vision and hearing: unimpaired or sufficiently corrected (glasses, hearing aid, etc.) - Sufficient knowledge of German - Sufficient language skills (documented in the Aphasie-Check-Liste short version) - Disease status: patients undergoing inpatient or outpatient treatment at the Clinic and Polyclinic for Neurology - Cognitive status: patients with subjective cognitive impairment, mild cognitive impairment and mild dementia of various etiologies - Consent: consented and signed
Exclusion criteria
Exclusion criteria: Control group: - Vision and hearing: impaired (so that the instructions cannot be conveyed either audibly or visually) - Limited knowledge of German - Substantial language impairments (documented in the Aphasie-Check-Liste short version) - Disease status: known neurological diseases - Cognitive status: substantial impairments - Consent: not consented, not signed Clinical patients: - Vision and hearing: impaired (so that instructions cannot be conveyed either audibly or visually) - Limited knowledge of German - Substantial language impairments (documented in the Aphasie-Check-Liste short version) - Disease status: patients in whom neurological diseases have been reliably ruled out. Moderate or severe illnesses that interfere with the ability to complete the survey - Cognitive status: neither subjective nor psychometrically verifiable cognitive impairment, patients with severe dementia (DemTect = 6 points) - Consent: not consented, not signed
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary objective: The aim of the present study is to apply and validate a newly developed, visually designed, multidimensional screening instrument (Picture-based assessment of subjective deficits in cognition and ADL; Pic-ADL) for the language-reduced assessment of subjectively experienced changes in cognition and ADL-activities in a neurological cohort (including healthy control subjects). In this way, the differential diagnosis of age-associated cognitive changes vs. MCI vs. mild dementia should be improved. | — |
Countries
Germany
Contacts
Uniklinik Köln